FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

17517311000001104: Neupro 2mg/24hours transdermal patches (Mawdsley-Brooks & Company Ltd) 28 patch (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 28-Jul 2010. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
60589701000001114 Neupro 2mg/24hours transdermal patches (Mawdsley-Brooks & Company Ltd) 28 patch (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
60589801000001117 Neupro 2mg/24hours transdermal patches (Mawdsley-Brooks & Company Ltd) 28 patch en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Neupro 2mg/24hours transdermal patches (Mawdsley-Brooks & Company Ltd) 28 patch Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Neupro 2mg/24hours transdermal patches (Mawdsley-Brooks & Company Ltd) 28 patch Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Neupro 2mg/24hours transdermal patches (Mawdsley-Brooks & Company Ltd) 28 patch Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel import true Inferred relationship Existential restriction modifier
Neupro 2mg/24hours transdermal patches (Mawdsley-Brooks & Company Ltd) 28 patch Is a Rotigotine 2mg/24hours patches 28 patch true Inferred relationship Existential restriction modifier
Neupro 2mg/24hours transdermal patches (Mawdsley-Brooks & Company Ltd) 28 patch Has AMP Neupro 2mg/24hours transdermal patches (Mawdsley-Brooks & Company Ltd) true Inferred relationship Existential restriction modifier
Neupro 2mg/24hours transdermal patches (Mawdsley-Brooks & Company Ltd) 28 patch Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Neupro 2mg/24hours transdermal patches (Mawdsley-Brooks & Company Ltd) 28 patch VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Neupro 2mg/24hours transdermal patches (Mawdsley-Brooks & Company Ltd) 28 patch VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Neupro 2mg/24hours transdermal patches (Mawdsley-Brooks & Company Ltd) 28 patch Has specific active ingredient Rotigotine true Inferred relationship Existential restriction modifier
Neupro 2mg/24hours transdermal patches (Mawdsley-Brooks & Company Ltd) 28 patch Has dispensed dose form Prolonged-release transdermal patch true Inferred relationship Existential restriction modifier
Neupro 2mg/24hours transdermal patches (Mawdsley-Brooks & Company Ltd) 28 patch Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Neupro 2mg/24hours transdermal patches (Mawdsley-Brooks & Company Ltd) 28 patch Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Neupro 2mg/24hours transdermal patches (Mawdsley-Brooks & Company Ltd) 28 patch Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Neupro 2mg/24hours transdermal patches (Mawdsley-Brooks & Company Ltd) 28 patch Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start